Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | BRD4770 |
Synonyms | |
Therapy Description |
BRD4770 inhibits the histone methyltransferase EHMT2 (G9A), resulting in decreased H3K9 di- and trimethylation, decreased proliferation, cell cycle arrest, and cell senescence (PMID: 2536950, PMID: 31822519). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BRD4770 | BRD-4770|BRD 4770 | EHMT2 Inhibitor 5 | BRD4770 inhibits the histone methyltransferase EHMT2 (G9A), resulting in decreased H3K9 di- and trimethylation, decreased proliferation, cell cycle arrest, and cell senescence (PMID: 2536950, PMID: 31822519). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|